This pipeline computes the correlation between cancer subtypes identified by different molecular patterns and selected clinical features.
Testing the association between subtypes identified by 8 different clustering approaches and 12 clinical features across 128 patients, 3 significant findings detected with P value < 0.05 and Q value < 0.25.
-
6 subtypes identified in current cancer cohort by 'Copy Number Ratio CNMF subtypes'. These subtypes correlate to 'LYMPH.NODE.METASTASIS' and 'NUMBER.OF.LYMPH.NODES'.
-
4 subtypes identified in current cancer cohort by 'METHLYATION CNMF'. These subtypes do not correlate to any clinical features.
-
CNMF clustering analysis on RPPA data identified 4 subtypes that do not correlate to any clinical features.
-
Consensus hierarchical clustering analysis on RPPA data identified 3 subtypes that do not correlate to any clinical features.
-
CNMF clustering analysis on sequencing-based mRNA expression data identified 3 subtypes that do not correlate to any clinical features.
-
Consensus hierarchical clustering analysis on sequencing-based mRNA expression data identified 3 subtypes that correlate to 'LYMPH.NODE.METASTASIS'.
-
3 subtypes identified in current cancer cohort by 'MIRSEQ CNMF'. These subtypes do not correlate to any clinical features.
-
3 subtypes identified in current cancer cohort by 'MIRSEQ CHIERARCHICAL'. These subtypes do not correlate to any clinical features.
Clinical Features |
Statistical Tests |
Copy Number Ratio CNMF subtypes |
METHLYATION CNMF |
RPPA CNMF subtypes |
RPPA cHierClus subtypes |
RNAseq CNMF subtypes |
RNAseq cHierClus subtypes |
MIRSEQ CNMF |
MIRSEQ CHIERARCHICAL |
Time to Death | logrank test |
0.0233 (1.00) |
0.56 (1.00) |
0.245 (1.00) |
0.25 (1.00) |
0.503 (1.00) |
0.829 (1.00) |
0.593 (1.00) |
0.199 (1.00) |
AGE | ANOVA |
0.0632 (1.00) |
0.0677 (1.00) |
0.473 (1.00) |
0.164 (1.00) |
0.733 (1.00) |
0.63 (1.00) |
0.233 (1.00) |
0.766 (1.00) |
GENDER | Fisher's exact test |
0.549 (1.00) |
0.0368 (1.00) |
0.633 (1.00) |
0.196 (1.00) |
0.251 (1.00) |
0.195 (1.00) |
0.155 (1.00) |
0.46 (1.00) |
KARNOFSKY PERFORMANCE SCORE | ANOVA |
0.698 (1.00) |
0.854 (1.00) |
0.465 (1.00) |
0.342 (1.00) |
0.877 (1.00) |
0.962 (1.00) |
0.73 (1.00) |
0.453 (1.00) |
NUMBERPACKYEARSSMOKED | ANOVA |
0.259 (1.00) |
0.785 (1.00) |
0.657 (1.00) |
0.677 (1.00) |
0.718 (1.00) |
0.566 (1.00) |
0.465 (1.00) |
0.345 (1.00) |
STOPPEDSMOKINGYEAR | ANOVA |
0.101 (1.00) |
0.266 (1.00) |
0.955 (1.00) |
0.56 (1.00) |
0.34 (1.00) |
0.302 (1.00) |
0.805 (1.00) |
0.481 (1.00) |
TOBACCOSMOKINGHISTORYINDICATOR | ANOVA |
0.535 (1.00) |
0.606 (1.00) |
0.258 (1.00) |
0.412 (1.00) |
0.604 (1.00) |
0.318 (1.00) |
0.843 (1.00) |
0.946 (1.00) |
DISTANT METASTASIS | Chi-square test |
0.471 (1.00) |
0.525 (1.00) |
0.108 (1.00) |
0.154 (1.00) |
0.39 (1.00) |
0.168 (1.00) |
0.97 (1.00) |
0.771 (1.00) |
LYMPH NODE METASTASIS | Chi-square test |
0.00135 (0.118) |
0.054 (1.00) |
0.082 (1.00) |
0.426 (1.00) |
0.142 (1.00) |
0.00134 (0.118) |
0.0573 (1.00) |
0.0737 (1.00) |
NUMBER OF LYMPH NODES | ANOVA |
0.00189 (0.162) |
0.223 (1.00) |
0.201 (1.00) |
0.121 (1.00) |
0.973 (1.00) |
0.141 (1.00) |
0.145 (1.00) |
0.106 (1.00) |
TUMOR STAGECODE | ANOVA | ||||||||
NEOPLASM DISEASESTAGE | Chi-square test |
0.0462 (1.00) |
0.0942 (1.00) |
0.279 (1.00) |
0.199 (1.00) |
0.738 (1.00) |
0.415 (1.00) |
0.0443 (1.00) |
0.0261 (1.00) |
Cluster Labels | 1 | 2 | 3 | 4 | 5 | 6 |
---|---|---|---|---|---|---|
Number of samples | 13 | 41 | 20 | 26 | 10 | 15 |
P value = 0.0233 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 118 | 31 | 0.1 - 131.2 (6.9) |
subtype1 | 13 | 2 | 2.2 - 118.9 (7.2) |
subtype2 | 39 | 12 | 0.1 - 131.2 (6.6) |
subtype3 | 19 | 4 | 0.4 - 100.5 (6.4) |
subtype4 | 23 | 5 | 0.5 - 46.8 (8.9) |
subtype5 | 10 | 5 | 3.6 - 12.9 (7.3) |
subtype6 | 14 | 3 | 1.0 - 75.3 (4.3) |
P value = 0.0632 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 124 | 67.1 (10.7) |
subtype1 | 13 | 67.0 (11.4) |
subtype2 | 41 | 66.9 (10.8) |
subtype3 | 20 | 67.8 (9.0) |
subtype4 | 25 | 63.5 (12.2) |
subtype5 | 10 | 64.9 (7.2) |
subtype6 | 15 | 74.4 (8.6) |
P value = 0.549 (Chi-square test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 33 | 92 |
subtype1 | 1 | 12 |
subtype2 | 12 | 29 |
subtype3 | 5 | 15 |
subtype4 | 6 | 20 |
subtype5 | 4 | 6 |
subtype6 | 5 | 10 |
P value = 0.698 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 37 | 78.1 (16.3) |
subtype1 | 5 | 86.0 (5.5) |
subtype2 | 8 | 75.0 (20.7) |
subtype3 | 7 | 78.6 (18.6) |
subtype4 | 11 | 78.2 (16.6) |
subtype5 | 2 | 85.0 (7.1) |
subtype6 | 4 | 70.0 (16.3) |
P value = 0.259 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 77 | 35.6 (21.8) |
subtype1 | 11 | 26.0 (27.0) |
subtype2 | 22 | 32.0 (17.8) |
subtype3 | 14 | 35.6 (21.1) |
subtype4 | 13 | 40.5 (14.8) |
subtype5 | 7 | 49.9 (24.4) |
subtype6 | 10 | 38.1 (27.8) |
P value = 0.101 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 63 | 1991.6 (16.9) |
subtype1 | 8 | 1989.2 (24.5) |
subtype2 | 20 | 1990.0 (15.7) |
subtype3 | 10 | 1985.8 (19.0) |
subtype4 | 12 | 2001.0 (7.6) |
subtype5 | 4 | 2004.8 (9.2) |
subtype6 | 9 | 1985.1 (16.0) |
P value = 0.535 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 119 | 2.6 (1.1) |
subtype1 | 12 | 3.0 (1.0) |
subtype2 | 38 | 2.4 (1.1) |
subtype3 | 19 | 2.7 (1.2) |
subtype4 | 26 | 2.7 (1.3) |
subtype5 | 9 | 2.9 (1.2) |
subtype6 | 15 | 2.4 (1.1) |
P value = 0.471 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 73 | 4 | 47 |
subtype1 | 7 | 1 | 5 |
subtype2 | 22 | 1 | 18 |
subtype3 | 9 | 0 | 10 |
subtype4 | 20 | 0 | 6 |
subtype5 | 6 | 1 | 3 |
subtype6 | 9 | 1 | 5 |
P value = 0.00135 (Chi-square test), Q value = 0.12
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 71 | 14 | 24 | 4 | 10 |
subtype1 | 3 | 2 | 2 | 1 | 5 |
subtype2 | 31 | 3 | 5 | 1 | 1 |
subtype3 | 10 | 1 | 5 | 0 | 3 |
subtype4 | 18 | 2 | 5 | 0 | 0 |
subtype5 | 4 | 3 | 1 | 1 | 1 |
subtype6 | 5 | 3 | 6 | 1 | 0 |
P value = 0.00189 (ANOVA), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 94 | 1.9 (3.8) |
subtype1 | 9 | 1.8 (2.7) |
subtype2 | 32 | 0.9 (1.9) |
subtype3 | 14 | 0.9 (1.3) |
subtype4 | 17 | 1.5 (2.3) |
subtype5 | 8 | 2.0 (4.1) |
subtype6 | 14 | 5.8 (7.4) |
P value = 0.0462 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 35 | 40 | 44 |
subtype1 | 1 | 4 | 2 | 6 |
subtype2 | 0 | 11 | 20 | 9 |
subtype3 | 0 | 8 | 4 | 7 |
subtype4 | 0 | 6 | 10 | 7 |
subtype5 | 0 | 3 | 2 | 5 |
subtype6 | 0 | 3 | 2 | 10 |
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 30 | 45 | 33 | 20 |
P value = 0.56 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 121 | 32 | 0.1 - 131.2 (6.8) |
subtype1 | 29 | 5 | 0.8 - 118.9 (6.4) |
subtype2 | 44 | 15 | 0.4 - 131.2 (7.7) |
subtype3 | 28 | 5 | 0.7 - 37.8 (6.4) |
subtype4 | 20 | 7 | 0.1 - 46.8 (8.0) |
P value = 0.0677 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 127 | 67.2 (10.6) |
subtype1 | 29 | 67.3 (10.3) |
subtype2 | 45 | 68.4 (9.6) |
subtype3 | 33 | 63.3 (12.2) |
subtype4 | 20 | 70.7 (9.5) |
P value = 0.0368 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 34 | 94 |
subtype1 | 10 | 20 |
subtype2 | 16 | 29 |
subtype3 | 3 | 30 |
subtype4 | 5 | 15 |
P value = 0.854 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 38 | 78.4 (16.2) |
subtype1 | 7 | 82.9 (15.0) |
subtype2 | 10 | 79.0 (15.2) |
subtype3 | 16 | 76.2 (18.9) |
subtype4 | 5 | 78.0 (13.0) |
P value = 0.785 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 78 | 36.1 (22.1) |
subtype1 | 19 | 31.8 (23.9) |
subtype2 | 32 | 36.8 (21.2) |
subtype3 | 21 | 38.2 (21.7) |
subtype4 | 6 | 39.5 (26.1) |
P value = 0.266 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 64 | 1991.8 (16.8) |
subtype1 | 12 | 1995.2 (15.1) |
subtype2 | 25 | 1988.9 (16.0) |
subtype3 | 17 | 1997.1 (16.3) |
subtype4 | 10 | 1986.2 (20.7) |
P value = 0.606 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 2.6 (1.1) |
subtype1 | 28 | 2.5 (1.2) |
subtype2 | 42 | 2.6 (1.0) |
subtype3 | 33 | 2.8 (1.3) |
subtype4 | 19 | 2.4 (1.1) |
P value = 0.525 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 76 | 4 | 47 |
subtype1 | 18 | 2 | 9 |
subtype2 | 24 | 1 | 20 |
subtype3 | 20 | 0 | 13 |
subtype4 | 14 | 1 | 5 |
P value = 0.054 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 73 | 14 | 25 | 4 | 10 |
subtype1 | 10 | 5 | 9 | 1 | 4 |
subtype2 | 31 | 5 | 5 | 2 | 2 |
subtype3 | 24 | 3 | 3 | 1 | 2 |
subtype4 | 8 | 1 | 8 | 0 | 2 |
P value = 0.223 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 94 | 1.9 (3.8) |
subtype1 | 21 | 2.3 (3.7) |
subtype2 | 35 | 1.1 (2.5) |
subtype3 | 24 | 1.7 (4.7) |
subtype4 | 14 | 3.6 (4.8) |
P value = 0.0942 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 36 | 41 | 45 |
subtype1 | 1 | 7 | 6 | 15 |
subtype2 | 0 | 11 | 20 | 12 |
subtype3 | 0 | 13 | 11 | 8 |
subtype4 | 0 | 5 | 4 | 10 |
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 12 | 10 | 14 | 17 |
P value = 0.245 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 52 | 20 | 0.4 - 118.9 (8.3) |
subtype1 | 12 | 4 | 5.7 - 49.9 (10.9) |
subtype2 | 10 | 5 | 1.8 - 100.5 (5.5) |
subtype3 | 13 | 2 | 0.5 - 19.5 (6.6) |
subtype4 | 17 | 9 | 0.4 - 118.9 (14.9) |
P value = 0.473 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 52 | 67.3 (9.8) |
subtype1 | 12 | 63.9 (9.2) |
subtype2 | 10 | 69.5 (9.3) |
subtype3 | 13 | 66.5 (10.2) |
subtype4 | 17 | 69.1 (10.3) |
P value = 0.633 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 21 | 32 |
subtype1 | 6 | 6 |
subtype2 | 5 | 5 |
subtype3 | 5 | 9 |
subtype4 | 5 | 12 |
P value = 0.465 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 11 | 80.0 (16.7) |
subtype1 | 5 | 88.0 (4.5) |
subtype2 | 1 | 70.0 (NA) |
subtype3 | 1 | 60.0 (NA) |
subtype4 | 4 | 77.5 (25.0) |
P value = 0.657 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 27 | 32.1 (17.5) |
subtype1 | 9 | 27.6 (12.4) |
subtype2 | 5 | 28.8 (18.4) |
subtype3 | 6 | 35.2 (20.4) |
subtype4 | 7 | 37.9 (21.6) |
P value = 0.955 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 21 | 1990.1 (16.1) |
subtype1 | 6 | 1989.7 (18.5) |
subtype2 | 2 | 1979.0 (11.3) |
subtype3 | 5 | 1992.8 (13.9) |
subtype4 | 8 | 1991.5 (17.9) |
P value = 0.258 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 48 | 2.3 (1.1) |
subtype1 | 12 | 2.6 (0.9) |
subtype2 | 8 | 1.9 (0.8) |
subtype3 | 14 | 2.1 (1.1) |
subtype4 | 14 | 2.6 (1.2) |
P value = 0.108 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 41 | 2 | 10 |
subtype1 | 7 | 2 | 3 |
subtype2 | 10 | 0 | 0 |
subtype3 | 11 | 0 | 3 |
subtype4 | 13 | 0 | 4 |
P value = 0.082 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 33 | 5 | 11 | 1 | 2 |
subtype1 | 9 | 1 | 0 | 0 | 2 |
subtype2 | 4 | 1 | 5 | 0 | 0 |
subtype3 | 10 | 0 | 3 | 0 | 0 |
subtype4 | 10 | 3 | 3 | 1 | 0 |
P value = 0.201 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 34 | 1.5 (3.0) |
subtype1 | 5 | 0.0 (0.0) |
subtype2 | 7 | 3.4 (4.1) |
subtype3 | 9 | 0.9 (1.5) |
subtype4 | 13 | 1.5 (3.3) |
P value = 0.279 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 11 | 19 | 18 |
subtype1 | 1 | 5 | 4 | 2 |
subtype2 | 0 | 2 | 2 | 6 |
subtype3 | 0 | 2 | 6 | 3 |
subtype4 | 0 | 2 | 7 | 7 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 14 | 17 | 22 |
P value = 0.25 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 52 | 20 | 0.4 - 118.9 (8.3) |
subtype1 | 14 | 5 | 1.9 - 49.9 (8.3) |
subtype2 | 17 | 10 | 0.4 - 118.9 (8.2) |
subtype3 | 21 | 5 | 0.5 - 100.5 (7.7) |
P value = 0.164 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 52 | 67.3 (9.8) |
subtype1 | 14 | 63.5 (9.6) |
subtype2 | 17 | 70.2 (9.0) |
subtype3 | 21 | 67.5 (10.2) |
P value = 0.196 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 21 | 32 |
subtype1 | 8 | 6 |
subtype2 | 7 | 10 |
subtype3 | 6 | 16 |
P value = 0.342 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 11 | 80.0 (16.7) |
subtype1 | 4 | 90.0 (0.0) |
subtype2 | 4 | 72.5 (23.6) |
subtype3 | 3 | 76.7 (15.3) |
P value = 0.677 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 27 | 32.1 (17.5) |
subtype1 | 9 | 30.4 (15.6) |
subtype2 | 8 | 29.1 (18.5) |
subtype3 | 10 | 36.1 (19.4) |
P value = 0.56 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 21 | 1990.1 (16.1) |
subtype1 | 4 | 1997.8 (13.0) |
subtype2 | 9 | 1987.0 (16.8) |
subtype3 | 8 | 1989.8 (17.2) |
P value = 0.412 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 48 | 2.3 (1.1) |
subtype1 | 13 | 2.3 (0.9) |
subtype2 | 14 | 2.6 (1.1) |
subtype3 | 21 | 2.1 (1.2) |
P value = 0.154 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 41 | 2 | 10 |
subtype1 | 9 | 2 | 3 |
subtype2 | 13 | 0 | 4 |
subtype3 | 19 | 0 | 3 |
P value = 0.426 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 33 | 5 | 11 | 1 | 2 |
subtype1 | 11 | 1 | 1 | 0 | 1 |
subtype2 | 8 | 3 | 5 | 1 | 0 |
subtype3 | 14 | 1 | 5 | 0 | 1 |
P value = 0.121 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 34 | 1.5 (3.0) |
subtype1 | 7 | 0.6 (1.5) |
subtype2 | 13 | 2.8 (4.3) |
subtype3 | 14 | 0.8 (1.3) |
P value = 0.199 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 11 | 19 | 18 |
subtype1 | 0 | 6 | 5 | 3 |
subtype2 | 0 | 2 | 5 | 9 |
subtype3 | 1 | 3 | 9 | 6 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 49 | 31 | 35 |
P value = 0.503 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 108 | 30 | 0.1 - 131.2 (7.0) |
subtype1 | 44 | 9 | 0.1 - 100.5 (6.5) |
subtype2 | 30 | 11 | 1.3 - 131.2 (6.3) |
subtype3 | 34 | 10 | 0.4 - 75.3 (8.1) |
P value = 0.733 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 114 | 66.8 (10.8) |
subtype1 | 48 | 65.9 (11.7) |
subtype2 | 31 | 67.8 (9.1) |
subtype3 | 35 | 67.2 (11.3) |
P value = 0.251 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 32 | 83 |
subtype1 | 10 | 39 |
subtype2 | 9 | 22 |
subtype3 | 13 | 22 |
P value = 0.877 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 34 | 77.6 (16.9) |
subtype1 | 19 | 78.4 (16.8) |
subtype2 | 5 | 74.0 (11.4) |
subtype3 | 10 | 78.0 (20.4) |
P value = 0.718 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 68 | 35.3 (22.7) |
subtype1 | 24 | 38.1 (28.2) |
subtype2 | 21 | 32.5 (18.5) |
subtype3 | 23 | 35.1 (20.1) |
P value = 0.34 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 58 | 1991.6 (17.3) |
subtype1 | 20 | 1994.7 (19.5) |
subtype2 | 18 | 1993.2 (15.8) |
subtype3 | 20 | 1987.0 (15.9) |
P value = 0.604 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 109 | 2.6 (1.1) |
subtype1 | 46 | 2.5 (1.3) |
subtype2 | 30 | 2.7 (1.1) |
subtype3 | 33 | 2.7 (1.0) |
P value = 0.39 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 69 | 3 | 42 |
subtype1 | 32 | 1 | 15 |
subtype2 | 16 | 2 | 13 |
subtype3 | 21 | 0 | 14 |
P value = 0.142 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 67 | 11 | 22 | 4 | 9 |
subtype1 | 25 | 4 | 13 | 0 | 6 |
subtype2 | 19 | 2 | 7 | 2 | 1 |
subtype3 | 23 | 5 | 2 | 2 | 2 |
P value = 0.973 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 86 | 1.9 (3.9) |
subtype1 | 31 | 2.0 (3.1) |
subtype2 | 29 | 2.0 (4.0) |
subtype3 | 26 | 1.8 (4.8) |
P value = 0.738 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 34 | 37 | 39 |
subtype1 | 1 | 15 | 13 | 17 |
subtype2 | 0 | 7 | 13 | 11 |
subtype3 | 0 | 12 | 11 | 11 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 37 | 17 | 61 |
P value = 0.829 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 108 | 30 | 0.1 - 131.2 (7.0) |
subtype1 | 36 | 9 | 0.4 - 75.3 (7.9) |
subtype2 | 16 | 7 | 4.5 - 131.2 (7.0) |
subtype3 | 56 | 14 | 0.1 - 100.5 (6.3) |
P value = 0.63 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 114 | 66.8 (10.8) |
subtype1 | 37 | 67.6 (11.2) |
subtype2 | 17 | 64.6 (8.8) |
subtype3 | 60 | 67.0 (11.2) |
P value = 0.195 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 32 | 83 |
subtype1 | 14 | 23 |
subtype2 | 5 | 12 |
subtype3 | 13 | 48 |
P value = 0.962 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 34 | 77.6 (16.9) |
subtype1 | 10 | 78.0 (20.4) |
subtype2 | 3 | 80.0 (10.0) |
subtype3 | 21 | 77.1 (16.5) |
P value = 0.566 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 68 | 35.3 (22.7) |
subtype1 | 24 | 31.7 (17.5) |
subtype2 | 13 | 35.0 (20.7) |
subtype3 | 31 | 38.3 (26.9) |
P value = 0.302 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 58 | 1991.6 (17.3) |
subtype1 | 22 | 1987.2 (16.3) |
subtype2 | 10 | 1996.3 (15.9) |
subtype3 | 26 | 1993.4 (18.3) |
P value = 0.318 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 109 | 2.6 (1.1) |
subtype1 | 36 | 2.7 (1.1) |
subtype2 | 15 | 2.9 (0.9) |
subtype3 | 58 | 2.5 (1.2) |
P value = 0.168 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 69 | 3 | 42 |
subtype1 | 21 | 0 | 16 |
subtype2 | 8 | 0 | 9 |
subtype3 | 40 | 3 | 17 |
P value = 0.00134 (Chi-square test), Q value = 0.12
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 67 | 11 | 22 | 4 | 9 |
subtype1 | 25 | 6 | 1 | 2 | 2 |
subtype2 | 13 | 0 | 1 | 2 | 1 |
subtype3 | 29 | 5 | 20 | 0 | 6 |
P value = 0.141 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 86 | 1.9 (3.9) |
subtype1 | 29 | 1.6 (4.5) |
subtype2 | 15 | 0.5 (1.0) |
subtype3 | 42 | 2.7 (4.0) |
P value = 0.415 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 34 | 37 | 39 |
subtype1 | 0 | 11 | 14 | 11 |
subtype2 | 0 | 6 | 8 | 3 |
subtype3 | 1 | 17 | 15 | 25 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 27 | 60 | 35 |
P value = 0.593 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 115 | 30 | 0.1 - 131.2 (6.9) |
subtype1 | 23 | 3 | 0.8 - 118.9 (5.3) |
subtype2 | 57 | 18 | 0.4 - 49.9 (6.9) |
subtype3 | 35 | 9 | 0.1 - 131.2 (8.3) |
P value = 0.233 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 121 | 67.0 (10.9) |
subtype1 | 26 | 69.1 (12.2) |
subtype2 | 60 | 65.3 (10.6) |
subtype3 | 35 | 68.3 (10.1) |
P value = 0.155 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 33 | 89 |
subtype1 | 4 | 23 |
subtype2 | 16 | 44 |
subtype3 | 13 | 22 |
P value = 0.73 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 38 | 78.4 (16.2) |
subtype1 | 7 | 82.9 (9.5) |
subtype2 | 25 | 77.6 (18.5) |
subtype3 | 6 | 76.7 (12.1) |
P value = 0.465 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 73 | 35.6 (22.1) |
subtype1 | 16 | 29.6 (23.2) |
subtype2 | 38 | 37.7 (20.2) |
subtype3 | 19 | 36.2 (25.1) |
P value = 0.805 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 62 | 1991.9 (17.1) |
subtype1 | 14 | 1990.9 (21.8) |
subtype2 | 29 | 1993.4 (14.7) |
subtype3 | 19 | 1990.3 (17.5) |
P value = 0.843 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 2.6 (1.2) |
subtype1 | 26 | 2.6 (1.3) |
subtype2 | 58 | 2.6 (1.1) |
subtype3 | 32 | 2.7 (1.2) |
P value = 0.97 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 72 | 3 | 46 |
subtype1 | 15 | 1 | 10 |
subtype2 | 37 | 1 | 22 |
subtype3 | 20 | 1 | 14 |
P value = 0.0573 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 71 | 12 | 23 | 4 | 10 |
subtype1 | 12 | 5 | 5 | 2 | 2 |
subtype2 | 41 | 5 | 6 | 2 | 6 |
subtype3 | 18 | 2 | 12 | 0 | 2 |
P value = 0.145 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 91 | 1.9 (3.8) |
subtype1 | 21 | 2.7 (5.4) |
subtype2 | 42 | 1.0 (2.4) |
subtype3 | 28 | 2.6 (4.2) |
P value = 0.0443 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 36 | 39 | 41 |
subtype1 | 1 | 6 | 5 | 13 |
subtype2 | 0 | 21 | 24 | 13 |
subtype3 | 0 | 9 | 10 | 15 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 17 | 88 | 17 |
P value = 0.199 (logrank test), Q value = 1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 115 | 30 | 0.1 - 131.2 (6.9) |
subtype1 | 13 | 1 | 1.5 - 118.9 (6.7) |
subtype2 | 85 | 23 | 0.1 - 131.2 (7.0) |
subtype3 | 17 | 6 | 0.8 - 46.8 (5.1) |
P value = 0.766 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 121 | 67.0 (10.9) |
subtype1 | 16 | 67.2 (13.6) |
subtype2 | 88 | 66.6 (10.8) |
subtype3 | 17 | 68.7 (8.3) |
P value = 0.46 (Fisher's exact test), Q value = 1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 33 | 89 |
subtype1 | 3 | 14 |
subtype2 | 27 | 61 |
subtype3 | 3 | 14 |
P value = 0.453 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 38 | 78.4 (16.2) |
subtype1 | 5 | 82.0 (11.0) |
subtype2 | 31 | 77.4 (17.3) |
subtype3 | 2 | 85.0 (7.1) |
P value = 0.345 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 73 | 35.6 (22.1) |
subtype1 | 10 | 32.4 (26.1) |
subtype2 | 52 | 34.3 (20.5) |
subtype3 | 11 | 44.5 (26.0) |
P value = 0.481 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 62 | 1991.9 (17.1) |
subtype1 | 9 | 1996.6 (18.3) |
subtype2 | 43 | 1990.1 (18.0) |
subtype3 | 10 | 1995.2 (11.4) |
P value = 0.946 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 2.6 (1.2) |
subtype1 | 16 | 2.6 (1.3) |
subtype2 | 83 | 2.6 (1.1) |
subtype3 | 17 | 2.7 (1.2) |
P value = 0.771 (Chi-square test), Q value = 1
nPatients | M0 | M1 | MX |
---|---|---|---|
ALL | 72 | 3 | 46 |
subtype1 | 9 | 1 | 7 |
subtype2 | 52 | 2 | 34 |
subtype3 | 11 | 0 | 5 |
P value = 0.0737 (Chi-square test), Q value = 1
nPatients | N0 | N1 | N2 | N3 | NX |
---|---|---|---|---|---|
ALL | 71 | 12 | 23 | 4 | 10 |
subtype1 | 8 | 4 | 2 | 1 | 2 |
subtype2 | 57 | 5 | 15 | 2 | 8 |
subtype3 | 6 | 3 | 6 | 1 | 0 |
P value = 0.106 (ANOVA), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 91 | 1.9 (3.8) |
subtype1 | 12 | 1.6 (3.4) |
subtype2 | 64 | 1.5 (3.1) |
subtype3 | 15 | 3.8 (6.1) |
P value = 0.0261 (Chi-square test), Q value = 1
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 1 | 36 | 39 | 41 |
subtype1 | 1 | 3 | 4 | 7 |
subtype2 | 0 | 29 | 32 | 24 |
subtype3 | 0 | 4 | 3 | 10 |
-
Cluster data file = BLCA-TP.mergedcluster.txt
-
Clinical data file = BLCA-TP.clin.merged.picked.txt
-
Number of patients = 128
-
Number of clustering approaches = 8
-
Number of selected clinical features = 12
-
Exclude small clusters that include fewer than K patients, K = 3
consensus non-negative matrix factorization clustering approach (Brunet et al. 2004)
Resampling-based clustering method (Monti et al. 2003)
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, one-way analysis of variance (Howell 2002) was applied to compare the clinical values between tumor subtypes using 'anova' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
For binary clinical features, two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.